Concepedia
Statistics
Publications
41
Citations
1.4K
H-Index
20
Active since
2005
Affiliations
Dana-Farber Cancer Institute(Current)
University of Bologna
Azienda USL di Bologna
Harvard University
Brigham and Women's Hospital
Alessandro Di Federico is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.
Top concepts
MedicineOncologyPathologyLung CancerRadiation OncologyImmunologyEngineeringImmunotherapyCancer TherapyComputer Science
Publications per year
2005–2025
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer
Biagio Ricciuti, Giuseppe Lamberti, Sreekar Reddy Puchala et al. · Journal of Clinical Oncology · 2024 · 100 citations · Full text
STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
Alessandro Di Federico, Andrea De Giglio, Claudia Parisi et al. · European Journal of Cancer · 2021 · 98 citations · Full text
Oncology, Keap1 Mutations, Medicine +9
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials
Alessandro Di Federico, Alessandro Rizzo, Riccardo Carloni et al. · Expert Opinion on Investigational Drugs · 2021 · 97 citations
rev.ng: a unified binary analysis framework to recover CFGs and function boundaries
Alessandro Di Federico, Mathias Payer, Giovanni Agosta · 2017 · 79 citations · Full text
Engineering, Verification, Function Boundaries +24
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti et al. · Journal of Thoracic Oncology · 2023 · 79 citations · Full text
Advanced Nsclc, Cancer Immunosurveillance, Medicine +7
1–5 of 41